Literature DB >> 34458943

Prevalence, correlates, and impact of sleep disturbance in Chinese meningioma patients.

Dandan Zhang1,2, Jing Wang3, Xixi Gu1, Zhifeng Gu4, Liren Li5, Chen Dong1,4, Rui Zhao6, Xiaomei Zhang7.   

Abstract

PURPOSE: Sleep disturbance is common in meningioma patients and may lead to disease aggravation and decreases health-related quality of life (HRQoL). However, the sleep quality of meningioma patients newly diagnosed and ready for surgery has not been well clarified in China. This study aims to evaluate the prevalence, correlates, and impact of sleep disturbance among Chinese meningioma patients.
METHODS: In this cross-sectional study, meningioma patients were recruited from the Affiliated Hospital of Nantong University from January 2020 to November 2020. A series of questionnaires were applied: the 0-10 Numerical Rating Scale (NRS), the Hospital Anxiety and Depression Scale (HADS), the Multidimensional Fatigue Inventory (MFI-20), the Epworth Sleepiness Scale (ESS), the Short-Form 36 (SF-36), the Pittsburgh Sleep Quality Index (PSQI). Independent samples t test, Mann-Whitney U test, chi-square analysis, Pearson/Spearman correlation, and binary logistic regression were used to analyze the data.
RESULTS: One hundred meningioma patients completed the questionnaires. Sleep disturbance affected 43% of the meningioma patients and was linked to many concomitant symptoms, such as headache, fatigue, anxiety, and depression. Binary logistic regression indicated that fatigue and headache were independently associated with sleep disturbance of meningioma patients. Meanwhile, severe sleep disturbance led to lower quality of life.
CONCLUSIONS: These findings demonstrated that a considerable number of meningioma patients newly diagnosed and ready for surgery suffered from sleep disturbance, potentially contributing to impair HRQoL. Medical personnel should pay more attention to meningioma patients with sleep disturbance and take effective measures to improve sleep quality, with the ultimate goal to improve their HRQoL.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Fatigue; Headache; Meningioma; Quality of life; Sleep quality

Mesh:

Year:  2021        PMID: 34458943     DOI: 10.1007/s00520-021-06504-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  48 in total

1.  Impaired survival and long-term neurological problems in benign meningioma.

Authors:  Hanna van Alkemade; Michelle de Leau; Edith M T Dieleman; Jan W P F Kardaun; Rob van Os; W Peter Vandertop; Wouter R van Furth; Lukas J A Stalpers
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

Review 2.  Hypothalamic regulation of sleep and circadian rhythms.

Authors:  Clifford B Saper; Thomas E Scammell; Jun Lu
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

3.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordan Xu; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2016-10-01       Impact factor: 12.300

Review 4.  Effects of sleep and sleep loss on immunity and cytokines.

Authors:  Michael Irwin
Journal:  Brain Behav Immun       Date:  2002-10       Impact factor: 7.217

5.  Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas.

Authors:  Martin L Waagemans; David van Nieuwenhuizen; Monica Dijkstra; Miriam Wumkes; Clemens M F Dirven; Sieger Leenstra; Jaap C Reijneveld; Martin Klein; Lukas J A Stalpers
Journal:  Neurosurgery       Date:  2011-07       Impact factor: 4.654

6.  Quality of life after surgery for intracranial meningioma.

Authors:  Luke S Benz; Margaret R Wrensch; Joellen M Schildkraut; Melissa L Bondy; Joshua L Warren; Joseph L Wiemels; Elizabeth B Claus
Journal:  Cancer       Date:  2017-09-13       Impact factor: 6.860

Review 7.  Meningiomas.

Authors:  Ian R Whittle; Colin Smith; Parthiban Navoo; Donald Collie
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

Review 8.  Epilepsy and brain tumors.

Authors:  Dario J Englot; Edward F Chang; Charles J Vecht
Journal:  Handb Clin Neurol       Date:  2016

9.  Pre-operative and post-operative psychiatric manifestations in patients with supratentorial meningiomas.

Authors:  Kalyan Bommakanti; Padmaja Gaddamanugu; Suvarna Alladi; Aniruddh Kumar Purohit; Santoshi Kumari Chadalawadi; Shailaja Mekala; Shanmukhi Somayajula
Journal:  Clin Neurol Neurosurg       Date:  2016-05-17       Impact factor: 1.876

Review 10.  Cognitive deficits in adult patients with brain tumours.

Authors:  Martin J B Taphoorn; Martin Klein
Journal:  Lancet Neurol       Date:  2004-03       Impact factor: 44.182

View more
  1 in total

1.  Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.

Authors:  Satoshi Yokoyama; Chihiro Nakagawa; Kouichi Hosomi
Journal:  Support Care Cancer       Date:  2021-10-01       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.